<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

COVID Consequences in 2021: The European Trauma & Extremities Markets

4/20/21 7:45 AM

European Trauma & Extremities COVID Consequences in 2021 PreviewSmartTRAK outlines consequences COVID-19 is expected to have on the European Trauma & Extremities Market

Twenty-five years of orthopedic business planning has taught me to monitor certain non-business factors when setting goals. Trends in weather patterns, age demographics, lifestyle and activities can have a direct influence on market growth. In 2020, the COVID-19 pandemic negatively impacted the European market with the shutdown of various countries and the ensuing changes in lifestyle such as reduced travel, work and sporting activities. In 2020, SmartTRAK predicted the European Trauma market fell by around 25% with extremities at nearly -50% in the midst of COVID-19 lockdowns. Similar market pressures are also expected during 2021.

Download the complete  "European Trauma & Extremities: COVID Consequences in  2021" article

 expects surgical procedures to recover but at a slower pace than initially thought due to the stress and pressure hospital staff have been under and their ability to return to normal work. The UK NHS Providers Group warned on February 1 that traumatized and exhausted medical staff will need time to recover before tackling the backlog of procedures. The number of people waiting for non-urgent surgeries by the UK’s National Health Service (NHS) has risen from 1,615 to 192,000 due to the pandemic. (BBC.com) ...

To download and read the entire "European Trauma & Extremities: COVID Consequences in 2021" market outlook article, which outlines in detail some of the biggest consequences COVID-19 is expected to have on the European Trauma & Extremities markets, please click the button below.Download the Article

SmartTRAK is kicking off 2021 with some exciting new product launches, including Pediatric Extremities, Pediatric Trauma and Arthroscopic Technologies. Click here see what we have on tap in the coming months.


Tim Jeavons
Written by Tim Jeavons

Director, European Orthopaedic Content & Sales 24+ years’ experience in Orthopedics with experience in Trauma, Extremities, and Orthobiologics. Previously held senior global marketing positions at Stryker and DePuy Synthes. Tim is based in Geneva, Switzerland.

    Recent Articles